Fri, Apr 19, 2024
The 15th International & 21st National Congress on
Quality Improvement in Clinical Laboratories
Milad Tower, Tehran - Iran
30April - 3May, 2024
| Post date: 2019/04/6 |
Laboratory Diagnosis of Human Papillomavirus (HPV)
1- Antiviral screening of four plant extracts against acyclovir resistant herpes simplex virus type-1. July 2017 Pak. J. Pharm. Sci., Vol.30, No.4(Suppl), , pp.1407-1411.
2- Detection of Human Metapneumovirus and Respiratory Syncytial Virus by Real-Time Polymerase Chain Reaction Among Hospitalized Young Children in Iran. 2016 Mar Jundishapur J.
2- Detection of Human Metapneumovirus and Respiratory Syncytial Virus by Real-Time Polymerase Chain Reaction Among Hospitalized Young Children in Iran. 2016 Mar Jundishapur J.
Abstract
Human Papillomavirus (HPV) is the most common sexually transmitted virus. Of more than 100 HPV types that have been detected, approximately 60 types have the ability to produce common warts, which are present in different parts of the body, such as hands and feet, and 40 types are associated with sexual transmitted diseases. Although most HPV infections do not cause any symptoms or clinical disease, long-lasting HPV infections in genital tract, may lead to the development of lesions and conditions such as Condylomata acuminata , intraepithelial neoplasia, preeclampsia and cancer. HPV is the causative agent of the most cervical cancers and other malignancies such as vaginal, penile, and anal cancers. HPV infections are divided into low-risk and high-risk HPV categories. High-risk HPV infections may cause cervical or other anogenital carcinomas. Cervical carcinoma is the second most common malignancy affecting women.
Diagnosis of HPV infections is very important in the prevention, control and treatment of patients. One of the main goals of the “Laboratory Diagnosis of Human Papillomavirus” panel is to evaluate the performance and quality of HPV diagnostic techniques, currently being used in clinical laboratories. Discussions on linical manifestation, epidemiology of HPV infections and cervical cancer in Iran as well as early HPV testing in cervical carcinoma screening will be presented in this panel. The quality assurance of molecular tests for the diagnosis of Human papillomavirus in clinical laboratories, will also be discussed.
Human Papillomavirus (HPV) is the most common sexually transmitted virus. Of more than 100 HPV types that have been detected, approximately 60 types have the ability to produce common warts, which are present in different parts of the body, such as hands and feet, and 40 types are associated with sexual transmitted diseases. Although most HPV infections do not cause any symptoms or clinical disease, long-lasting HPV infections in genital tract, may lead to the development of lesions and conditions such as Condylomata acuminata , intraepithelial neoplasia, preeclampsia and cancer. HPV is the causative agent of the most cervical cancers and other malignancies such as vaginal, penile, and anal cancers. HPV infections are divided into low-risk and high-risk HPV categories. High-risk HPV infections may cause cervical or other anogenital carcinomas. Cervical carcinoma is the second most common malignancy affecting women.
Diagnosis of HPV infections is very important in the prevention, control and treatment of patients. One of the main goals of the “Laboratory Diagnosis of Human Papillomavirus” panel is to evaluate the performance and quality of HPV diagnostic techniques, currently being used in clinical laboratories. Discussions on linical manifestation, epidemiology of HPV infections and cervical cancer in Iran as well as early HPV testing in cervical carcinoma screening will be presented in this panel. The quality assurance of molecular tests for the diagnosis of Human papillomavirus in clinical laboratories, will also be discussed.
Dr. Masoud Parsania
My educational background is:
1985 – 1990: BSc in Medical Laboratory Sciences. Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
1995 – 1998: Master of Science in Virology. Iran Medical Sciences University, Tehran / Iran.
2002 – 2008: PhD
I am associate professor in Department of Microbiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. I have supervised thesis of more than 20 MSc and medical students, some of which focused on molecular analysis of Human papillomavirus.
Email: mparsania
iautmu.ac.ir
iautmu.ac.ir
View: 1464 Time(s) |
Print: 452 Time(s) |
Email: 0 Time(s) |
0 Comment(s)